Related Experiment Videos
Cyclosporine: what clinicians need to know
1Psoriasis Treatment Center and Phototherapy Unit, Psychodermatology Clinic, University of California San Franscisco Medical Center 94118, USA.
Dermatologic Clinics
|October 1, 1995
Summary
Cyclosporine effectively treats psoriasis, offering significant anti-inflammatory benefits for severe cases. Long-term safety requires further study due to potential kidney and blood pressure issues.
Area of Science:
- Dermatology
- Immunology
- Pharmacology
Background:
- Psoriasis is a chronic inflammatory skin condition.
- Recalcitrant psoriasis presents treatment challenges.
- Cyclosporine offers potent anti-inflammatory properties distinct from other treatments like methotrexate.
Purpose of the Study:
- To evaluate the efficacy and safety of cyclosporine in treating psoriasis.
- To discuss the advantages of cyclosporine in managing difficult psoriasis cases.
- To explore cyclosporine's role in current psoriasis treatment strategies.
Main Methods:
- Review of existing literature on cyclosporine for psoriasis.
- Analysis of cyclosporine's anti-inflammatory mechanisms.
- Comparison of cyclosporine's side-effect profile with other dermatologic agents.
Main Results:
- Cyclosporine demonstrates high efficacy in short-term psoriasis treatment, particularly for intensely inflamed conditions.
- Its unique side-effect profile offers advantages over agents like methotrexate.
- Concerns regarding nephrotoxicity and hypertension limit its long-term continuous use (beyond 1 year).
Conclusions:
- Cyclosporine is a valuable therapeutic option for recalcitrant psoriasis, especially in the short term.
- Careful monitoring is essential due to potential long-term side effects.
- Cyclosporine is a welcome addition to combination and rotational therapy approaches for psoriasis management.